Abstract
Clopidogrel in combination with aspirin administered as a loading dose of 450 mg reveals an accelerated antiplatelet effect in the early hours after first administration in patients undergoing coronary stent placement.
Publication types
-
Clinical Trial
-
Comparative Study
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Angioplasty, Balloon, Coronary
-
Clopidogrel
-
Coronary Disease / blood
-
Coronary Disease / therapy*
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Female
-
Humans
-
Male
-
Middle Aged
-
Platelet Aggregation Inhibitors / administration & dosage*
-
Platelet Aggregation Inhibitors / adverse effects
-
Platelet Function Tests*
-
Prospective Studies
-
Recurrence
-
Stents*
-
Ticlopidine / administration & dosage*
-
Ticlopidine / adverse effects
-
Ticlopidine / analogs & derivatives*
Substances
-
Platelet Aggregation Inhibitors
-
Clopidogrel
-
Ticlopidine